UK’s NICE hits back at claims it spent taxpayer money on champagne

13 January 2014
alcohol-big

The UK’s National Institute for Health and Care Excellence (NICE) has refuted claims by one of the UK’s most popular newspapers that it spent £3,346 ($5,516) at Searcy’s, a chain of champagne bars in London.

In a front page story on Saturday, the Daily Mail claimed that NICE “racked up £115,000 on taxpayer-funded credit cards in the past two and a half years, including £5,000 on luxury hotels. Other splurges include £3,800 on camcorders, £620 on furniture and garden ware and £3,346 at Searcy’s, a chain of champagne bars in London.” NICE has denied the claims, insisting that Searcy’s also manages conference facilities, and the money was spent on room hire at the Royal College of GPs and the Commonwealth Club, where NICE has held meetings of its advisory committees.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight



More Features in Pharmaceutical